BNTC
Benitec Biopharma Inc.
Biotechnology · Healthcare · United States
8.74
close · 2026-10-30
value
75
cheaper than peers75
quality
92
stronger fundamentals92
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, latest year | -5.5% | 81 |
| earnings yield, 1 year ago | -12.0% | 68 |
| earnings yield, latest year | -11.2% | 68 |
| earnings yield, 2 years ago | -14.0% | 67 |
| cash flow yield, 3 years ago | -5.9% | 66 |
| cash flow yield, 1 year ago | -7.7% | 66 |
| cash flow yield, 2 years ago | -6.4% | 64 |
| price to book | 1.70× | 63 |
| earnings yield, 3 years ago | -161.6% | 25 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | -29.6% | 89 |
| debt to equity | 0.5% | 83 |
| operating margin | 0.0% | 50 |
3 of 4 measures available
Facts
| market cap | $305M |
| free cash flow | -$7.1M |
| employees | 19 |
| first trade | 2014-06-24 |
| next earnings | 2026-09-14 |
| fundamentals updated | 2026-09-14 |
Annual history
| measure | 2026 | 2025 | 2024 | 2023 |
| diluted eps | -0.98 | -1.05 | -1.22 | -14.12 |
| free cash flow | -$16.6M | -$23.6M | -$19.6M | -$18.0M |
| net income | -$45.5M | -$37.9M | -$21.8M | -$19.6M |
| revenue | $0 | $0 | $0 | $75,000 |
| unusual items | $120,000 | -$71,000 | $39,000 | -$418,000 |